Has tryptophan any anticonvulsive effect?

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Electroconvulsive therapy (ECT) is a widely used treatment for severe depression.
• The role of neurotransmitters, such as serotonin, in modulating ECT efficacy is an area of ongoing research.
• L-tryptophan (L-TP), a precursor to serotonin, has been investigated for its potential to influence mood and neurological processes.

Purpose of the Study:

• To investigate the effect of L-tryptophan (L-TP) on electroconvulsive therapy (ECT) in patients with depression.
• To determine if L-TP alters the electrical stimulation threshold required for inducing seizures during ECT.
• To assess the impact of L-TP on the duration of ECT-induced seizures.

Main Methods:

• An intra-individual crossover trial design was employed.
• Depressed patients received either unilateral ECT alone or unilateral ECT combined with L-TP.
• L-TP was administered orally at a dose of 6 g the day before ECT and 3 g four hours prior to ECT.
• Seizure duration was measured using electroencephalogram (EEG) records.

Main Results:

• The time of electrical stimulation needed to induce generalized seizures was comparable between the L-TP + ECT and ECT alone groups.
• This indicates that L-TP does not elevate the threshold for ECT-induced convulsions.
• The mean duration of seizures was significantly shorter in patients treated with L-TP + ECT compared to those treated with ECT alone.

Conclusions:

• L-tryptophan does not appear to increase the seizure threshold for electroconvulsive therapy.
• L-tryptophan may exert an inhibitory influence on the ability to sustain epileptic activity during ECT.
• These findings suggest a potential modulatory role for L-TP in ECT, specifically in shortening seizure duration.